Geode Capital Management »

Outlook Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 229k 7.38
2024-03-31 $1.8M 152k 11.94

More positions owned by Geode Capital Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Outlook Therapeutics

Dr. Jeffrey R. Jay, M.D.
Tang Capital Management
BlackRock
Sphera Funds Management
Vanguard Group
Altium Capital Management
Caligan Partners
Schonfeld Strategic Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
LVW Advisors
Nuveen Asset Management
Susquehanna Fundamental Investments
Charles Schwab Investment Management

View all funds holding Outlook Therapeutics